Elucidata Corp. Raises Seed Funding To Modify Drug Discovery
A data science company called Elucidata Corporation announced that it raised a seed funding amounting to $1.7 million carried out by Hyperplane Venture Capital.
Along with Hyperplane Venture, other angel investors were a part of the seed funding round as well. The backed company has already started working well and has gained profitability.
Elucidata Corporation plans to utilize these funds in the expansion process and to transform drug discovery. It wants to grow its team and operations in New Delhi and also introduce some fresh discovery tools for the process of discovering drugs. The company is planning to grow and expand extensively.
“The potential for Elucidata’s platform to improve the lives of countless people — from those suffering from diabetes to a wide range of other dise...